Scientific Resources for Ultrasensitive Blood-Based Biomarker Detection
Explore scientific resources advancing ultrasensitive protein biomarker detection in blood. Taudia’s library of research posters, application notes, white papers, webinars, and technical articles highlights how the SPLASH™ single-wash proximity ligation assay enables sensitive, specific, and scalable quantitation of low-abundance neurological biomarkers, including pTau-217, BD pTau-217, eMTBR-Tau243, Aβ42, Aβ40, NfL, GFAP, using accessible qPCR workflows. Discover data and practical insights supporting multiplex biomarker analysis, Alzheimer’s disease research, neurodegenerative disease staging, clinical trial screening, and longitudinal brain health monitoring.
Development of an ultrasensitive, scalable Solid Phase Ligation Assay with Single wasH (SPLASH) based immunoassay for the quantitation of LRRK2
Presented at AD/PD 2026
Multi-platform Quantitation Of Alzheimer’s Disease Biomarkers Using A Multiplex Assay Compatible With qPCR and dPCR
Presented at AD/PD 2026
Simultaneous Quantitation of pTau-217, Aβ42, NfL, and GFAP in Plasma Using a Novel Multiplex Assay for Alzheimer’s Disease Staging and Monitoring
Presented at AD/PD 2026
Absolute quantitation of protein enabled by digital proximity ligation assay to enhance quality control of protein reference material
Presented at AAIC 2025
Flexible assay platform for the quantitation of blood-based biomarkers for early detection of Alzheimer’s Disease
Presented at AAIC 2025
Scalable ultrasenstive quantification of blood-based biomarkers for Alzheimer’s Disease
Presented at ADPD 2025
Multiplexed Biomarker Profiling of Alzheimer's Disease Samples
Discover how Taudia’s five-plex SPLASH™ assay enables simultaneous quantitation of pTau-217, Aβ42, Aβ40, NfL, and GFAP from a single plasma sample—delivering high sensitivity, reduced variability, and scalable workflows for Alzheimer’s disease staging and monitoring.
Single-well multiplexing: Quantify multiple proteins from the same sample without sacrificing performance.
Learn how SPLASH™ single-well multiplexing provides accurate duplex quantitation of neurodegenerative biomarkers using the same simple workflow as singleplex assays—allowing researchers to measure multiple proteins from one sample without sacrificing performance.
A Novel Dried Plasma Spot (DPS)-Based Workflow for Quantification of Alzheimer's Disease Diagnostic Biomarkers
Explore a novel DPS-based workflow combining ambient-stable sample collection with SPLASH™ ultrasensitive detection to quantify pTau-217 and Aβ42—offering a practical, scalable path to decentralized Alzheimer’s disease screening and longitudinal monitoring.
Blood-Based Biomarker’s for Alzheimer’s: Impact on Clinical Trial Screening
Learn how Taudia’s single-wash SPLASH platform enables fast, accessible, and ultrasensitive blood-based biomarker testing to transform Alzheimer’s diagnosis and accelerate therapeutic development
Multiplex Quantitation of pTau-217, Aβ40, Aβ42, NfL, and GFAP in Bio-Hermes-001 Cohort
See how Taudia’s SPLASH™ AD 5-plex precisely measures pTau-217, Aβ40, Aβ42, NfL, and GFAP from just 12.5 µL of plasma—and improves prediction of amyloid PET positivity.
AD is a growing public health challenge, with the number of affected Americans projected to reach 8.5 million by 2030...